Kung, Frank Fang Chien 孔繁建
Main board
| Organisation | Position | From | Until | Total Return |
CAGR total return |
CAGR relative return |
||
|---|---|---|---|---|---|---|---|---|
| 1 | Amyris, Inc. | DirDirector | 2017-11 | |||||
| 2 | Genelabs Technologies, Inc. | Pres, CEO, Co-FdrPresident, Chief Executive Officer, Co-Founder | 1983 | 1995 | ||||
| 3 | SSC HOLDCO (UK) LIMITED | DirDirector | 2020-11-27 | 2021-02-10 | ||||
| 4 | SSC INTERMEDIATECO LIMITED | DirDirector | 2020-11-27 | 2021-02-10 | ||||
| 5 | * | TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | NEDNon-Executive Director | 2016-01-19 | 2022-03-12 | -51.60% | -26.68% | -19.09% |
| 6 | Vivo Capital LLC | Mng Partner, FdrManaging Partner, Founder | 1997 | |||||
| Average | -26.68% | -19.09% |
Some data are hidden to fit your display. Rotate?
Total returns are measured from the latest of the start date, the appointment date and 3-Jan-1994 until the earliest of the end date, the resignation/removal date and the last trading date. CAGR is the annualised return and is not shown for periods under 180 days. Relative returns are to the Tracker Fund of HK (2800), starting from the latest of 12-Nov-1999, the appointment date and the chosen start date.
* = is or was HK primary-listed
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy